Cargando…
The Immune Epitope Database and Analysis Resource in Epitope Discovery and Synthetic Vaccine Design
The task of epitope discovery and vaccine design is increasingly reliant on bioinformatics analytic tools and access to depositories of curated data relevant to immune reactions and specific pathogens. The Immune Epitope Database and Analysis Resource (IEDB) was indeed created to assist biomedical r...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348633/ https://www.ncbi.nlm.nih.gov/pubmed/28352270 http://dx.doi.org/10.3389/fimmu.2017.00278 |
_version_ | 1782514272796934144 |
---|---|
author | Fleri, Ward Paul, Sinu Dhanda, Sandeep Kumar Mahajan, Swapnil Xu, Xiaojun Peters, Bjoern Sette, Alessandro |
author_facet | Fleri, Ward Paul, Sinu Dhanda, Sandeep Kumar Mahajan, Swapnil Xu, Xiaojun Peters, Bjoern Sette, Alessandro |
author_sort | Fleri, Ward |
collection | PubMed |
description | The task of epitope discovery and vaccine design is increasingly reliant on bioinformatics analytic tools and access to depositories of curated data relevant to immune reactions and specific pathogens. The Immune Epitope Database and Analysis Resource (IEDB) was indeed created to assist biomedical researchers in the development of new vaccines, diagnostics, and therapeutics. The Analysis Resource is freely available to all researchers and provides access to a variety of epitope analysis and prediction tools. The tools include validated and benchmarked methods to predict MHC class I and class II binding. The predictions from these tools can be combined with tools predicting antigen processing, TCR recognition, and B cell epitope prediction. In addition, the resource contains a variety of secondary analysis tools that allow the researcher to calculate epitope conservation, population coverage, and other relevant analytic variables. The researcher involved in vaccine design and epitope discovery will also be interested in accessing experimental published data, relevant to the specific indication of interest. The database component of the IEDB contains a vast amount of experimentally derived epitope data that can be queried through a flexible user interface. The IEDB is linked to other pathogen-specific and immunological database resources. |
format | Online Article Text |
id | pubmed-5348633 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-53486332017-03-28 The Immune Epitope Database and Analysis Resource in Epitope Discovery and Synthetic Vaccine Design Fleri, Ward Paul, Sinu Dhanda, Sandeep Kumar Mahajan, Swapnil Xu, Xiaojun Peters, Bjoern Sette, Alessandro Front Immunol Immunology The task of epitope discovery and vaccine design is increasingly reliant on bioinformatics analytic tools and access to depositories of curated data relevant to immune reactions and specific pathogens. The Immune Epitope Database and Analysis Resource (IEDB) was indeed created to assist biomedical researchers in the development of new vaccines, diagnostics, and therapeutics. The Analysis Resource is freely available to all researchers and provides access to a variety of epitope analysis and prediction tools. The tools include validated and benchmarked methods to predict MHC class I and class II binding. The predictions from these tools can be combined with tools predicting antigen processing, TCR recognition, and B cell epitope prediction. In addition, the resource contains a variety of secondary analysis tools that allow the researcher to calculate epitope conservation, population coverage, and other relevant analytic variables. The researcher involved in vaccine design and epitope discovery will also be interested in accessing experimental published data, relevant to the specific indication of interest. The database component of the IEDB contains a vast amount of experimentally derived epitope data that can be queried through a flexible user interface. The IEDB is linked to other pathogen-specific and immunological database resources. Frontiers Media S.A. 2017-03-14 /pmc/articles/PMC5348633/ /pubmed/28352270 http://dx.doi.org/10.3389/fimmu.2017.00278 Text en Copyright © 2017 Fleri, Paul, Dhanda, Mahajan, Xu, Peters and Sette. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Fleri, Ward Paul, Sinu Dhanda, Sandeep Kumar Mahajan, Swapnil Xu, Xiaojun Peters, Bjoern Sette, Alessandro The Immune Epitope Database and Analysis Resource in Epitope Discovery and Synthetic Vaccine Design |
title | The Immune Epitope Database and Analysis Resource in Epitope Discovery and Synthetic Vaccine Design |
title_full | The Immune Epitope Database and Analysis Resource in Epitope Discovery and Synthetic Vaccine Design |
title_fullStr | The Immune Epitope Database and Analysis Resource in Epitope Discovery and Synthetic Vaccine Design |
title_full_unstemmed | The Immune Epitope Database and Analysis Resource in Epitope Discovery and Synthetic Vaccine Design |
title_short | The Immune Epitope Database and Analysis Resource in Epitope Discovery and Synthetic Vaccine Design |
title_sort | immune epitope database and analysis resource in epitope discovery and synthetic vaccine design |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348633/ https://www.ncbi.nlm.nih.gov/pubmed/28352270 http://dx.doi.org/10.3389/fimmu.2017.00278 |
work_keys_str_mv | AT fleriward theimmuneepitopedatabaseandanalysisresourceinepitopediscoveryandsyntheticvaccinedesign AT paulsinu theimmuneepitopedatabaseandanalysisresourceinepitopediscoveryandsyntheticvaccinedesign AT dhandasandeepkumar theimmuneepitopedatabaseandanalysisresourceinepitopediscoveryandsyntheticvaccinedesign AT mahajanswapnil theimmuneepitopedatabaseandanalysisresourceinepitopediscoveryandsyntheticvaccinedesign AT xuxiaojun theimmuneepitopedatabaseandanalysisresourceinepitopediscoveryandsyntheticvaccinedesign AT petersbjoern theimmuneepitopedatabaseandanalysisresourceinepitopediscoveryandsyntheticvaccinedesign AT settealessandro theimmuneepitopedatabaseandanalysisresourceinepitopediscoveryandsyntheticvaccinedesign AT fleriward immuneepitopedatabaseandanalysisresourceinepitopediscoveryandsyntheticvaccinedesign AT paulsinu immuneepitopedatabaseandanalysisresourceinepitopediscoveryandsyntheticvaccinedesign AT dhandasandeepkumar immuneepitopedatabaseandanalysisresourceinepitopediscoveryandsyntheticvaccinedesign AT mahajanswapnil immuneepitopedatabaseandanalysisresourceinepitopediscoveryandsyntheticvaccinedesign AT xuxiaojun immuneepitopedatabaseandanalysisresourceinepitopediscoveryandsyntheticvaccinedesign AT petersbjoern immuneepitopedatabaseandanalysisresourceinepitopediscoveryandsyntheticvaccinedesign AT settealessandro immuneepitopedatabaseandanalysisresourceinepitopediscoveryandsyntheticvaccinedesign |